memo - Magazine of European Medical Oncology

• Editorial

Are adjuvant therapies beyond all doubt?

Wolfgang Hilbe, Eberhard Gunsilius

• CECOG News

CECOG News

Christoph C. Zielinski

• Short review

Adjuvant therapy in non-small cell lung cancer: Current status and future perspectives

M. Filipits, R. Pirker

• Short review

Adjuvant chemotherapy in stage IB non-small cell lung cancer: if, when, how?

M. Dediu

• Short review

(Neo-)Adjuvant treatment of malignant thymoma

G. Pall

• Short review

Perioperative therapy in gastric cancer

E. Wöll

• Short review

Adjuvant therapy of stage II colorectal cancer – who will benefit from treatment?

H. Zwierzina

• Consensus report

Consensus on the medical treatment of colon cancer

G. Kornek, W. Scheithauer, R. Anghel, G. Bodoky, F. Ciardiello, T. Ciuleanu, R. Glynne-Jones, T. Gruenberger, I. Koza, J. Ocvirk, L. Petruzelka, G. Poston, G. Ramadori, W. Schmiegel, S. Segaert, J. Tabernero, H. Zwierzina, C. Zielinski

• Review article

Adjuvant chemotherapy in breast cancer

R. Bartsch, G. G. Steger

• Short review

Primary chemotherapy and maintenance therapy in epithelial ovarian cancer

A. G. Zeimet, D. Reimer, N. Concin, S. Braun, C. Marth

• Congress report

Congress report: 49th Annual Meeting of the American Society of Haematology, Georgia World Congress Center, December 8–11 2007, Atlanta, Georgia

S. Schmidt, M. Steurer

• Special article

Update on the treatment of hepatocellular carcinoma

M. Peck-Radosavljevic

• Announcement

Announcement